drug

sefaxersen

1 story · latest Sep 23, 2026

Status: Investigational
Code: RO7434656
Trials: 1 registered trial in coverage

Relationships

Developed by Roche

Timeline

Ionis and Roche report positive Phase 3 interim data for sefaxersen in IgA nephropathy

Sep 23Clinical readoutIonis Pharmaceuticals Roche

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.